News

   

Futura Medical plc Board Appointment

Futura Medical plc (AIM: FUM), a pharmaceutical company developing…

MinervaX provides clinical and leadership update

- Completed enrolment of 150 pregnant women in a Phase 2 study…

HEALTHCAP STRENGTHENS SENIOR TEAM

Mårten Steen Promoted to Co-Managing Partner Expanded team…

Arix today announces the following updates to its Board and Executive team

LONDON, 6 October 2021: Arix Bioscience plc (“Arix” or the…

Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation Officer

Industry veteran with decades of experience in company formation,…

Amber Implants VCFix® spinal system receives US FDA Breakthrough Designation

The Hague, Netherlands, 5 October 2021: Amber Implants, an innovative…

DelSiTech Awarded UnitaidExplore Funding for Innovations in Paediatric Healthcare

DelSiTech Awarded UnitaidExplore Funding for Innovations in Paediatric…

Versameb at Sachs 21st Annual Biotech in Europe Forum

Isabel Ferreira speaking on the “Platform Technologies and…

Optimum Strategic Communications Hosts 13th Annual Healthcare Investor Conference

- World Class Speakers from Biotech & Healthcare Industry…

Arix Bioscience plc Interim results for the six months ended 30 June 2021

LONDON, 12 August 2021: Arix Bioscience plc (“Arix”, LSE:…

Optimum Strategic Communications Expands Team to support ongoing growth

Optimum is pleased to announce the appointment of Stella Lempidaki. With…

Novo Holdings posts record income and returns of DKK 29 billion (EUR 4 billion) in 2020

Novo Holdings’ 2020 result is based on a strong performance…

Niall Kirk, Friend and Founder of Optimum Strategic Communications

It is with great sadness that we have to inform you that our…

Optimum Strategic Communications 12th Annual Healthcare Investor Conference

- Future of healthcare conference in partnership with Dechert…

Optimum recognised for its work in the M&A PR advisor league tables

The Optimum team is very proud to be recognised for our work…

Optimum European Healthcare Investor Survey

European investors continue actively investing in healthcare. The survey held in May 2020 includes responses from 24 of the most influential European VCs, investing approximately EUR 15.5 billion in aggregate in the Healthcare sector.

Optimum European Healthcare Investor Survey

Optimum Strategic Communications (Optimum), conducted a survey of European Venture Capital (VC) investors and the impact of COVID-19 on the Healthcare Sector.

We’d love to hear from you.

For more information about Optimum Strategic Communications, please get in touch.

© Optimum Strategic Communications.